The risk of chronic kidney disease development in adult patients with chronic hypoparathyroidism treated with rhPTH(1‐84): A retrospective cohort study
Clinical Endocrinology · 2023-04 · 98 (4) · 496-504
DOI: 10.1111/cen.14813 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Endocrinology, online erschienen am 28.08.2022. Verfasst von Lars Rejnmark und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Internal Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Hypoparathyroidism, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
This study assessed the risk of developing chronic kidney disease (CKD) and decline in estimated glomerular filtration rate (eGFR) over a period of up to 5 years in adult patients with chronic hypoparathyroidism treated with recombinant human parathyroid hormone (1‐84) (rhPTH[1‐84]) compared with a historical control cohort of patients not treated with rhPTH(1‐84).
Design
Retrospective cohort study of patients with chronic hypoparathyroidism treated with rhPTH(1‐84) derived from the REPLACE (NCT00732615), RELAY (NCT01268098), RACE (NCT01297309) and HEXT (NCT01199614, and its continuation study NCT02910466) clinical trials and a historical control cohort who did not receive PTH selected from an electronic medical record database. Patients One hundred and eighteen patients treated with rhPTH(1‐84) and 497 patient controls.
Measurements
Incident CKD was defined as ≥2 eGFR measurements
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Internal Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
- Takeda Pharmaceuticals USA, Inc., Lexington, Massachusetts, USA.
- Analysis Group, Inc., Boston, Massachusetts, USA.
- Division of Nephrology and Hypertension, Albany Medical College, Albany, New York, USA.
ORCID-Profile: Lars Rejnmark, Elvira O Gosmanova
Zitieren
APA
Rejnmark, L., Ayodele, O., Lax, A., Mu, F., Swallow, E., & Gosmanova, E. O. (2023). The risk of chronic kidney disease development in adult patients with chronic hypoparathyroidism treated with rhPTH(1‐84): A retrospective cohort study. Clinical Endocrinology, 98(4), 496-504. https://doi.org/10.1111/cen.14813
Vancouver
Rejnmark L, Ayodele O, Lax A, Mu F, Swallow E, Gosmanova EO. The risk of chronic kidney disease development in adult patients with chronic hypoparathyroidism treated with rhPTH(1‐84): A retrospective cohort study. Clinical Endocrinology. 2023;98(4):496-504. doi:10.1111/cen.14813
BibTeX
@article{Rejnmark2023,
author = {Rejnmark, Lars and Ayodele, Olulade and Lax, Angela and Mu, Fan and Swallow, Elyse and Gosmanova, Elvira O},
title = {The risk of chronic kidney disease development in adult patients with chronic hypoparathyroidism treated with rhPTH(1‐84): A retrospective cohort study},
journal = {Clinical Endocrinology},
year = {2023},
volume = {98},
number = {4},
pages = {496--504},
doi = {10.1111/cen.14813}
}
EUVIMED